MENU
NTLA
AS OF
Nov 19, 04:59 PM (EDT)
Price
$8.25
Change
-$0.22 (-2.60%)
Capitalization
954.44M
91 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
NTLA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Intellia Therapeutics (NTLA) Earnings Date & Reports

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

NTLA is expected to report earnings to rise 6.04% to -97 cents per share on February 19

Intellia Therapeutics NTLA Stock Earnings Reports
Q4'25
Est.
$-0.98
Q3'25
Beat
by $0.09
Q2'25
Beat
by $0.05
Q1'25
Beat
by $0.17
Q4'24
Beat
by $0.07
The last earnings report on November 06 showed earnings per share of -92 cents, beating the estimate of -100 cents. With 3.98M shares outstanding, the current market capitalization sits at 954.44M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
NTLA
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NTLA showed earnings on November 06, 2025. You can read more about the earnings report here.
View AI-Driven Trading for NTLA
A.I. Advisor
published General Information

General Information

a developer of proprietary, potentially curative therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
40 Erie Street
Phone
+1 857 285-6200
Employees
526
Web
https://www.intelliatx.com